Davis Selected Advisers Lowers stake in Monsanto Company (MON)

Monsanto Company (MON) : Davis Selected Advisers reduced its stake in Monsanto Company by 2.31% during the most recent quarter end. The investment management company now holds a total of 8,043,218 shares of Monsanto Company which is valued at $803.8 Million after selling 190,048 shares in Monsanto Company , the firm said in a disclosure report filed with the SEC on May 13, 2016.Monsanto Company makes up approximately 3.47% of Davis Selected Advisers’s portfolio.

Other Hedge Funds, Including , Institutional Capital reduced its stake in MON by selling 751,994 shares or 17.21% in the most recent quarter. The Hedge Fund company now holds 3,617,888 shares of MON which is valued at $361.6 Million. Monsanto Company makes up approx 3.86% of Institutional Capital’s portfolio.Archford Capital Strategies reduced its stake in MON by selling 158 shares or 0.66% in the most recent quarter. The Hedge Fund company now holds 23,923 shares of MON which is valued at $2.4 Million. Monsanto Company makes up approx 1.15% of Archford Capital Strategies’s portfolio.Linscomb Williams reduced its stake in MON by selling 14 shares or 0.13% in the most recent quarter. The Hedge Fund company now holds 11,097 shares of MON which is valued at $995,956. Monsanto Company makes up approx 0.11% of Linscomb Williams’s portfolio.Russell Frank Co boosted its stake in MON in the latest quarter, The investment management firm added 96,673 additional shares and now holds a total of 791,809 shares of Monsanto Company which is valued at $74.2 Million. Monsanto Company makes up approx 0.13% of Russell Frank Co’s portfolio.

Monsanto Company opened for trading at $111.42 and hit $113 on the upside on Wednesday, eventually ending the session at $111.68, with a gain of 2.18% or 2.38 points. The heightened volatility saw the trading volume jump to 1,31,67,916 shares. Company has a market cap of $48,787 M.

On the company’s financial health, Monsanto Company reported $2.42 EPS for the quarter, based on the information available during the earnings call on Apr 6, 2016. Analyst had a consensus estimate of $2.42. The company had revenue of $4532.00 million for the quarter, compared to analysts expectations of $4734.36 million. The company’s revenue was down -12.8 % compared to the same quarter last year.During the same quarter in the previous year, the company posted $2.90 EPS.

Many Wall Street Analysts have commented on Monsanto Company. Monsanto Company was Upgraded by Jefferies to ” Buy” on May 25, 2016. Shares were Reiterated by Deutsche Bank on Apr 7, 2016 to “Buy” and Lowered the Price Target to $ 100 from a previous price target of $105 .Monsanto Company was Downgraded by Citigroup to ” Neutral” on Mar 14, 2016.

Monsanto Company (Monsanto) is a provider of agricultural products for farmers. The Company’s seeds biotechnology trait products and herbicides provide farmers with solutions that improve productivity reduce the costs of farming and produce better foods for consumers and better feed for animals. It manages business in two segments: Seeds and Genomics and Agricultural Productivity. Through its Seeds and Genomics segment it produces seed brands including DEKALB Asgrow Deltapine Seminis and De Ruiter and it develops biotechnology traits that assist farmers in controlling insects and weeds. Through its Agricultural Productivity segment it manufactures Roundup brand herbicides and other herbicides and provides lawn-and-garden herbicide products for the residential market.

Leave a Reply

Monsanto Company - Is it time to Sell?

Top Brokerage Firms are advising their investors on Monsanto Company. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.